Overview

Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the efficacy and safety of clevidipine for treating Hypertensive emergencies(defined as systolic blood pressure >180 mmHg and/or diastolic blood pressure >120 mmHg, accompanied by acute organ damage).
Phase:
Phase 3
Details
Lead Sponsor:
Nanjing Yoko Biomedical Co., Ltd.
Treatments:
Clevidipine